MAP
Moody Aldrich Partners Portfolio holdings
AUM
$517M
1-Year Return
38.15%
This Quarter Return
+19.16%
1 Year Return
+38.15%
3 Year Return
+181.18%
5 Year Return
+335.56%
10 Year Return
–
AUM
$487M
AUM Growth
+$111M
(+29%)
Cap. Flow
+$78.8M
Cap. Flow
% of AUM
16.18%
Top 10 Holdings %
Top 10 Hldgs %
24.68%
Holding
170
New
47
Increased
65
Reduced
33
Closed
18
Top Buys
| 1 |
iShares MSCI ACWI ETF
ACWI
|
$45.9M |
| 2 |
Esperion Therapeutics
ESPR
|
$7.41M |
| 3 |
Mesa Laboratories
MLAB
|
$7.26M |
| 4 |
WSFS Financial
WSFS
|
$6.04M |
| 5 |
ICF International
ICFI
|
$5.99M |
Top Sells
| 1 |
Rexford Industrial Realty
REXR
|
$5.04M |
| 2 |
Steven Madden
SHOO
|
$4.93M |
| 3 |
Stifel
SF
|
$4.64M |
| 4 |
Dorman Products
DORM
|
$4.22M |
| 5 |
VG
Vonage Holdings Corporation
VG
|
$4.17M |
Sector Composition
| 1 | Industrials | 14.48% |
| 2 | Healthcare | 14.2% |
| 3 | Technology | 14.06% |
| 4 | Financials | 13.48% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
KB Home
KBH
$4.49B
| $2.59M | 0.53% |
+75,705
| New | +$2.59M |
|
77
NovoCure
NVCR
$1.34B
| $2.59M | 0.53% |
30,751
+885
| +3% | +$74.6K |
|
78
Haemonetics
HAE
$2.61B
| $2.53M | 0.52% |
21,973
+197
| +0.9% | +$22.6K |
|
79
Ascendis Pharma
ASND
$12B
| $2.52M | 0.52% |
+18,145
| New | +$2.52M |
|
80
AMN Healthcare
AMN
$775M
| $2.42M | 0.5% |
38,764
+354
| +0.9% | +$22.1K |
|
|
CHX
81
DELISTED
ChampionX
CHX
| $2.41M | 0.5% |
+71,440
| New | +$2.41M |
|
82
Iovance Biotherapeutics
IOVA
$796M
| $2.35M | 0.48% |
84,874
+1,311
| +2% | +$36.3K |
|
83
Cirrus Logic
CRUS
$5.92B
| $2.31M | 0.47% |
+27,994
| New | +$2.31M |
|
84
HealthEquity
HQY
$8.42B
| $2.27M | 0.47% |
30,595
+7,337
| +32% | +$543K |
|
85
Comfort Systems
FIX
$25.5B
| $2.25M | 0.46% |
45,129
+704
| +2% | +$35.1K |
|
86
SolarEdge
SEDG
$2.03B
| $2.21M | 0.45% |
23,204
+401
| +2% | +$38.1K |
|
87
Simpson Manufacturing
SSD
$8.03B
| $2.12M | 0.43% |
+26,356
| New | +$2.12M |
|
88
Azenta
AZTA
$1.35B
| $1.96M | 0.4% |
46,645
-19,570
| -30% | -$821K |
|
|
KRTX
89
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.94M | 0.4% |
+25,804
| New | +$1.94M |
|
90
Enphase Energy
ENPH
$4.78B
| $1.89M | 0.39% |
72,266
-4,026
| -5% | -$105K |
|
91
Albany International
AIN
$1.84B
| $1.88M | 0.39% |
24,798
-47,467
| -66% | -$3.6M |
|
|
DRNA
92
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.76M | 0.36% |
+79,961
| New | +$1.76M |
|
93
Natera
NTRA
$22.9B
| $1.7M | 0.35% |
50,412
+447
| +0.9% | +$15.1K |
|
94
Rogers Corp
ROG
$1.44B
| $1.63M | 0.34% |
13,084
-571
| -4% | -$71.2K |
|
|
BPMC
95
DELISTED
Blueprint Medicines
BPMC
| $1.48M | 0.31% |
18,522
-736
| -4% | -$59K |
|
|
NVTA
96
DELISTED
Invitae Corporation
NVTA
| $1.45M | 0.3% |
89,733
+20,104
| +29% | +$324K |
|
97
Kohl's
KSS
$1.84B
| $1.19M | 0.24% |
23,327
| – | – |
|
98
Capital One
COF
$145B
| $1.09M | 0.22% |
10,580
| – | – |
|
99
Ally Financial
ALLY
$12.8B
| $1.04M | 0.21% |
34,168
-4,826
| -12% | -$147K |
|
100
Robert Half
RHI
$3.8B
| $967K | 0.2% |
+15,317
| New | +$967K |
|